Deep learning enables rapid identification of potent DDR1 kinase inhibitors

Adam: A Method for Stochastic Optimization

Kingma, D. P., & Ba, J. (2014) · arXiv · doi:10.48550/arxiv.1412.6980 · Cited by 98,946 · see citing works

Learning Phrase Representations using RNN Encoder–Decoder for Statistical Machine Translation

Cho, K., van Merrienboer, B., Gulcehre, C., Bahdanau, D., Bougares, F., Schwenk, H., & Bengio, Y. (2014) · Proceedings of the 2014 Conference on Empirical Methods in Natural Language Processing (EMNLP) · doi:10.3115/v1/d14-1179 · Cited by 25,545 · see citing works

GAN（Generative Adversarial Nets）

淳司, 柴. (2017) · Journal of Japan Society for Fuzzy Theory and Intelligent Informatics · doi:10.3156/jsoft.29.5_177_2 · Cited by 19,268 · see citing works

UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations

Rappé, A. K., Casewit, C. J., Colwell, K. S., Goddard, W. A., & Skiff, W. M. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00051a040 · Cited by 10,603 · see citing works

Simple Statistical Gradient-Following Algorithms for Connectionist Reinforcement Learning

Williams, R. J. (1992) · Machine Learning · doi:10.1007/bf00992696 · Cited by 7,936 · see citing works

How to improve R&D productivity: the pharmaceutical industry's grand challenge

Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · see citing works

A Nonlinear Mapping for Data Structure Analysis

Sammon, J. W. (1969) · IEEE Transactions on Computers · doi:10.1109/t-c.1969.222678 · Cited by 3,419 · see citing works

Tensor-Train Decomposition

Oseledets, I. (2011) · SIAM Journal on Scientific Computing · doi:10.1137/090752286 · Cited by 3,302 · see citing works

Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules

Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106 · see citing works

ZINC: A Free Tool to Discover Chemistry for Biology

Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S. D., & Coleman, R. G. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3001277 · Cited by 2,533 · see citing works

Quantifying the chemical beauty of drugs

Bickerton, G. R., Paolini, G. V., Besnard, J., Mureşan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,301 · see citing works

Inverse molecular design using machine learning: Generative models for matter engineering

Sánchez-Lengeling, B., & Aspuru‐Guzik, A. (2018) · Science · doi:10.1126/science.aat2663 · Cited by 2,087 · see citing works

Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions

Ertl, P., & Schuffenhauer, A. (2009) · Journal of Cheminformatics · doi:10.1186/1758-2946-1-8 · Cited by 1,939 · see citing works

Planning chemical syntheses with deep neural networks and symbolic AI

Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847 · see citing works

Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules.

Gómez‐Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera‐Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru‐Guzik, A. (2018) · Cambridge University Engineering Department Publications Database · doi:10.17863/cam.34134 · Cited by 1,813 · see citing works

Prediction of Physicochemical Parameters by Atomic Contributions

Wildman, S. A., & Crippen, G. M. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990307l · Cited by 1,491 · see citing works

GuacaMol: Benchmarking Models for de Novo Molecular Design

Brown, N., Fiscato, M., Segler, M. H. S., & Vaucher, A. C. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00839 · Cited by 895 · see citing works

Applications of Deep Learning in Biomedicine

Mamoshina, P., Vieira, A., Lane, E., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00982 · Cited by 701 · see citing works

Deep learning for molecular design—a review of the state of the art

Elton, D. C., Boukouvalas, Z., Fuge, M. D., & Chung, P. W. (2019) · Molecular Systems Design & Engineering · doi:10.1039/c9me00039a · Cited by 683 · see citing works

Self-organizing semantic maps

Ritter, H. J., & Kohonen, T. (1989) · Biological Cybernetics · doi:10.1007/bf00203171 · Cited by 622 · see citing works

druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico

Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587 · see citing works

Objective-Reinforced Generative Adversarial Networks (ORGAN) for Sequence Generation ModelsPreprint

Guimaraes, G. L., Sánchez-Lengeling, B., Outeiral, C., Farias, P. L. C., & Aspuru‐Guzik, A. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1705.10843 · Cited by 419 · see citing works

Reinforced Adversarial Neural Computer for de Novo Molecular Design

Lane, E., Asadulaev, A., Ivanenkov, Y. A., Aladinskiy, V., Sánchez-Lengeling, B., Aspuru‐Guzik, A., & Zhavoronkov, A. A. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00690 · Cited by 381 · see citing works

<i>De Novo</i> Design of Bioactive Small Molecules by Artificial Intelligence

Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373 · see citing works

The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology

Kadurin, A., Aliper, A., Kazennov, A., Mamoshina, P., Vanhaelen, Q., Khrabrov, K., & Zhavoronkov, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14073 · Cited by 350 · see citing works

The $2.6 Billion Pill — Methodologic and Policy Considerations

Avorn, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500848 · Cited by 322 · see citing works

Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery

Polykovskiy, D., Zhebrak, A., Vetrov, D., Ivanenkov, Y., Aladinskiy, V., Mamoshina, P., Bozdaganyan, M., Aliper, A., Zhavoronkov, A., & Kadurin, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00839 · Cited by 278 · see citing works

Adversarial Threshold Neural Computer for Molecular de Novo Design

Lane, E., Asadulaev, A., Vanhaelen, Q., Ivanenkov, Y. A., Aladinskaya, A. V., Aliper, A., & Zhavoronkov, A. A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01137 · Cited by 219 · see citing works

Discovery and Optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as Novel Selective and Orally Bioavailable Discoidin Domain Receptor 1 (DDR1) Inhibitors

Gao, M., Duan, L., Luo, J., Zhang, L., Lu, X., Zhang, Y., Zhang, Z., Tu, Z., Xu, Y., Ren, X., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301824k · Cited by 168 · see citing works

Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor

Kim, H.-G., Tan, L., Weisberg, E., Liu, F., Canning, P., Choi, H. G., Ezell, S. A., Wu, H., Zhao, Z., Wang, J., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400430t · Cited by 157 · see citing works

Optimizing distributions over molecular space. An Objective-Reinforced Generative Adversarial Network for Inverse-design Chemistry (ORGANIC)Preprint

Sánchez-Lengeling, B., Outeiral, C., Guimaraes, G. L., & Aspuru‐Guzik, A. (2017) · ChemRxiv · doi:10.26434/chemrxiv.5309668.v2 · Cited by 148 · see citing works

Tuning artificial intelligence on the de novo design of natural-product-inspired retinoid X receptor modulators

Merk, D., Grisoni, F., Friedrich, L., & Schneider, G. (2018) · Communications Chemistry · doi:10.1038/s42004-018-0068-1 · Cited by 136 · see citing works

DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome

Richter, H. G., Satz, A. L., Bedoucha, M., Buettelmann, B., Petersen, A. C., Harmeier, A., Hermosilla, R., Hochstrasser, R., Burger, D., Gsell, B., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00866 · Cited by 120 · see citing works

3D Molecular Representations Based on the Wave Transform for Convolutional Neural Networks

Kuzminykh, D., Polykovskiy, D. A., Kadurin, A., Zhebrak, A., Baskov, I., Nikolenko, S., Shayakhmetov, R., & Zhavoronkov, A. A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01134 · Cited by 107 · see citing works

Structural Mechanisms Determining Inhibition of the Collagen Receptor DDR1 by Selective and Multi-Targeted Type II Kinase Inhibitors

Canning, P., Tan, L., Chu, K., Lee, S. W., Gray, N. S., & Bullock, A. N. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.04.014 · Cited by 103 · see citing works

Synthesis of 1,1‐Diborylalkenes through a Brønsted Base Catalyzed Reaction between Terminal Alkynes and Bis(pinacolato)diboron

Morinaga, A., Nagao, K., Ohmiya, H., & Sawamura, M. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201509218 · Cited by 102 · see citing works

DDR1 role in fibrosis and its pharmacological targeting

Moll, S., Desmoulière, A., Moeller, M. J., Pache, J., Badi, L., Arcadu, F., Richter, H. G., Satz, A. L., Uhles, S., Cavalli, A., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.04.004 · Cited by 90 · see citing works

Synthesis and antitrichinellosis activity of some 2-substituted-[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-ones

Mavrova, A. T., Anichina, K. K., Vuchev, D., Tsenov, J. A., Kondeva, M. S., & Micheva, M. K. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.046 · Cited by 77 · see citing works

Small Molecule Discoidin Domain Receptor Kinase Inhibitors and Potential Medical Applications

Li, Y., Lu, X., Ren, X., & Ding, K. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5012319 · Cited by 72 · see citing works

Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors

Wang, Z., Bian, H., Bartual, S. G., Du, W., Luo, J., Zhao, H., Zhang, S., Mo, C., Zhou, Y., Xu, Y., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00140 · Cited by 67 · see citing works

Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors

Murray, C. W., Berdini, V., Buck, I. M., Carr, M. E., Cleasby, A., Coyle, J. E., Curry, J. E., Day, J. E. H., Day, P. J., Hearn, K., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00143 · Cited by 65 · see citing works

Prototype-Based Compound Discovery Using Deep Generative Models

Harel, S., & Radinsky, K. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00474 · Cited by 47 · see citing works

Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors

Wang, Z., Zhang, Y., Bartual, S. G., Luo, J., Xu, T., Du, W., Xun, Q., Tu, Z., Brekken, R. A., Ren, X., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00497 · Cited by 41 · see citing works

Discovery of a broad spectrum antiproliferative agent with selectivity for DDR1 kinase: cell line-based assay, kinase panel, molecular docking, and toxicity studies

Elkamhawy, A., Park, J., Cho, N., Sim, T., Pae, A. N., & Roh, E. J. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1004057 · Cited by 34 · see citing works

Preparation of diamines by lithiation–substitution of imidazolidines and pyrimidines

Ashweek, N. J., Coldham, I., Haxell, T. F. N., & Howard, S. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b301502e · Cited by 33 · see citing works

Synthesis and biological evaluation of novel dasatinib analogues as potent DDR 1 and DDR 2 kinase inhibitors

Liu, L., Hussain, M., Luo, J., Duan, A., Chen, C., Tu, Z., & Zhang, J. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12863 · Cited by 32 · see citing works

eCF309 : a potent, selective and cell-permeable mTOR inhibitor

Fraser, C., Carragher, N. O., & Unciti‐Broceta, A. (2015) · MedChemComm · doi:10.1039/c5md00493d · Cited by 23 · see citing works

Discovery of N-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs)

Wang, Q., Liu, F., Wang, B., Zou, F., Chen, C., Liu, X., Wang, A., Qi, S., Wang, W., Qi, Z., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00200 · Cited by 15 · see citing works

Crystal Packing: An Examination of the Packing of Molecules Approximately Isosteric with 4,5‐Dichlorophthalic Anhydride

Britton, D., Noland, W. E., Pinnow, M. J., & Young, V. G. (2003) · Helvetica Chimica Acta · doi:10.1002/hlca.200390102 · Cited by 8 · see citing works

AI in health and medicine

Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-021-01614-0 · Cited by 3,212 · see citing works

A guide to machine learning for biologists

Greener, J. G., Kandathil, S. M., Moffat, L., & Jones, D. T. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00407-0 · Cited by 2,127 · see citing works

Scientific discovery in the age of artificial intelligence.

Wang, H., Fu, T., Du, Y., Gao, W., Huang, K., Liu, Z., Chandak, P., Liu, S., Van Katwyk, P., Deac, A., et al. (2023) · Nature · doi:10.1038/s41586-023-06221-2 · Cited by 1,823 · see citing works

Artificial intelligence: A powerful paradigm for scientific research

Xu, Y., Liu, X., Cao, X., Huang, C., Liu, E., Qian, S., Liu, X., Wu, Y., Dong, F., Qiu, C.-W., et al. (2021) · The Innovation · doi:10.1016/j.xinn.2021.100179 · Cited by 1,726 · see citing works

Artificial intelligence to deep learning: machine intelligence approach for drug discovery

Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473 · see citing works

Computational approaches streamlining drug discovery

Sadybekov, A., & Katritch, V. (2023) · Nature · doi:10.1038/s41586-023-05905-z · Cited by 1,342 · see citing works

Drug discovery with explainable artificial intelligence

Jiménez-Luna, J., Grisoni, F., & Schneider, G. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-00236-4 · Cited by 1,063 · see citing works

Rethinking drug design in the artificial intelligence era

Schneider, P., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0050-3 · Cited by 894 · see citing works

Combining Machine Learning and Computational Chemistry for Predictive Insights Into Chemical Systems

Keith, J. A., Vassilev-Galindo, V., Cheng, B., Chmiela, S., Gastegger, M., Müller, K.-R., & Tkatchenko, A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00107 · Cited by 849 · see citing works

Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models

Polykovskiy, D., Zhebrak, A., Sanchez-Lengeling, B., Golovanov, S., Tatanov, O., Belyaev, S., Kurbanov, R., Artamonov, A., Aladinskiy, V., Veselov, M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565644 · Cited by 849 · see citing works

Machine Learning in Drug Discovery: A Review

Dara, S., Dhamercherla, S., Jadav, S. S., Babu, C. M., & Ahsan, M. J. (2021) · Artificial Intelligence Review · doi:10.1007/s10462-021-10058-4 · Cited by 843 · see citing works

Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics

Wang, Y., Zhang, S., Li, F., Zhou, Y., Zhang, Y., Wang, Z., Zhang, R., Zhu, J., Ren, Y., Tan, Y. C., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz981 · Cited by 794 · see citing works

Synthetic data in machine learning for medicine and healthcare

Chen, R. J., Lu, M. Y., Chen, T. Y., Williamson, D. F. K., & Mahmood, F. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00751-8 · Cited by 728 · see citing works

Self-Driving Laboratories for Chemistry and Materials Science

Tom, G., Schmid, S. P., Baird, S. G., Cao, Y., Darvish, K., Hao, H., Lo, S., Pablo-García, S., Rajaonson, E. M., Skreta, M., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00055 · Cited by 707 · see citing works

Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents

Zhou, Y., Zhang, Y., Lian, X., Li, F., Wang, C., Zhu, F., Qiu, Y., & Chen, Y. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab953 · Cited by 667 · see citing works

Big-Data Science in Porous Materials: Materials Genomics and Machine Learning

Jablonka, K. M., Ongari, D., Moosavi, S. M., & Smit, B. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00004 · Cited by 636 · see citing works

Nanoparticle synthesis assisted by machine learning

Tao, H., Wu, T., Aldeghi, M., Wu, T., Aspuru‐Guzik, A., & Kumacheva, E. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00337-5 · Cited by 558 · see citing works

Predicting drug response and synergy using a deep learning model of human cancer cells

Kuenzi, B. M., Park, J., Fong, S. H., Sanchez, K. S., Lee, J., Kreisberg, J. F., Ma, J., & Ideker, T. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.09.014 · Cited by 544 · see citing works

Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy

Pottier, C., Fresnais, M., Gilon, M., Jérusalem, G., Longuespée, R., & Sounni, N. E. (2020) · Cancers · doi:10.3390/cancers12030731 · Cited by 516 · see citing works

Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine

Serrano, D. R., Luciano, F. C., Anaya, B. J., Öngoren, B., Kara, A., Molina, G., Ramirez, B. I., Sánchez-Guirales, S. A., Simon, J. A., Tomietto, G., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101328 · Cited by 561 · see citing works

Identification of antimicrobial peptides from the human gut microbiome using deep learning

Ma, Y., Guo, Z., Xia, B., Zhang, Y., Liu, X., Yu, Y., Tang, N., Tong, X., Wang, M., Ye, X., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01226-0 · Cited by 503 · see citing works

REINVENT 2.0: An AI Tool for De Novo Drug Design

Blaschke, T., Arús-Pous, J., Chen, H., Margreitter, C., Tyrchan, C., Engkvist, O., Papadopoulos, K., & Patronov, A. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00915 · Cited by 496 · see citing works

Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions

Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429 · see citing works

The Synthesizability of Molecules Proposed by Generative Models

Gao, W., & Coley, C. W. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00174 · Cited by 405 · see citing works

Applications of Deep Learning in Molecule Generation and Molecular Property Prediction

Walters, W. P., & Barzilay, R. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00699 · Cited by 394 · see citing works

Transfer Learning for Drug Discovery

Cai, C., Wang, S., Xu, Y., Zhang, W., Tang, K., Ouyang, Q., Lai, L., & Pei, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02147 · Cited by 363 · see citing works

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Ren, F., Ding, X., Zheng, M., Korzinkin, M., Cai, X., Zhu, W., Mantsyzov, A., Aliper, A., Aladinskiy, V., Cao, Z., et al. (2023) · Chemical Science · doi:10.1039/d2sc05709c · Cited by 365 · see citing works

Advances in De Novo Drug Design: From Conventional to Machine Learning Methods

Mouchlis, V. D., Afantitis, A., Serra, A., Fratello, M., Papadiamantis, A. G., Aidinis, V., Lynch, I., Greco, D., & Melagraki, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041676 · Cited by 367 · see citing works

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

Ren, F., Aliper, A., Chen, J., Zhao, H., Rao, S., Kuppe, C., Ozerov, I. V., Zhang, M., Witte, K., Kruse, C., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02143-0 · Cited by 348 · see citing works

Amelioration of Alzheimer’s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow

Xie, C., Zhuang, X., Niu, Z., Ai, R., Lautrup, S., Zheng, S., Jiang, Y., Han, R., Gupta, T. S., Cao, S., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00819-5 · Cited by 347 · see citing works

Machine learning directed drug formulation development

Bannigan, P., Aldeghi, M., Bao, Z., Häse, F., Aspuru‐Guzik, A., & Allen, C. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.016 · Cited by 342 · see citing works

Reinvent 4: Modern AI–driven generative molecule design

Loeffler, H. H., He, J., Tibo, A., Janet, J. P., Voronov, A., Mervin, L., & Engkvist, O. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00812-5 · Cited by 385 · see citing works

AI-powered therapeutic target discovery

Pun, F. W., Ozerov, I. V., & Zhavoronkov, A. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.06.010 · Cited by 341 · see citing works

Generative models for molecular discovery: Recent advances and challenges

Bilodeau, C., Jin, W., Jaakkola, T., Barzilay, R., & Jensen, K. F. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1608 · Cited by 333 · see citing works

Generative Models as an Emerging Paradigm in the Chemical Sciences

Anstine, D. M., & Isayev, O. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c13467 · Cited by 320 · see citing works

Utilizing graph machine learning within drug discovery and development

Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R., Roberts, C., Tang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab159 · Cited by 313 · see citing works

Discovering Anti-Cancer Drugs via Computational Methods

Cui, W., Aouidate, A., Wang, S., Yu, Q., Li, Y.-H., & Yuan, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00733 · Cited by 310 · see citing works

AI in drug discovery and its clinical relevance

Qureshi, R., Irfan, M., Gondal, T. M., Khan, S., Wu, J., Hadi, M. U., Heymach, J., Le, X., Yan, H., & Alam, T. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17575 · Cited by 319 · see citing works

Empowering biomedical discovery with AI agents

Gao, S., Fang, A., Huang, Y., Giunchiglia, V., Noori, A., Schwarz, J. R., Ektefaie, Y., Kondic, J., & Zitnik, M. (2024) · Cell · doi:10.1016/j.cell.2024.09.022 · Cited by 315 · see citing works

De novo molecular design and generative models

Meyers, J., Fabian, B., & Brown, N. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.05.019 · Cited by 300 · see citing works

Deep generative molecular design reshapes drug discovery

Zeng, X., Wang, F., Luo, Y., Kang, S.-G., Tang, J., Lightstone, F. C., Fang, E. F., Cornell, W., Nussinov, R., & Cheng, F. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100794 · Cited by 295 · see citing works

Machine learning in clinical decision making

Adlung, L., Cohen, Y., Mor, U., & Elinav, E. (2021) · Med · doi:10.1016/j.medj.2021.04.006 · Cited by 304 · see citing works

Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine

Chen, Z., Lin, L., Wu, C., Li, C., Xu, R., & Sun, Y. H. (2021) · 癌症：英文版 · doi:10.1002/cac2.12215 · Cited by 291 · see citing works

Machine learning for antimicrobial peptide identification and design

Wan, F.-P., Wong, F., Collins, J. J., & de la Fuente-Núñez, C. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00152-x · Cited by 278 · see citing works

From machine learning to deep learning: Advances of the recent data-driven paradigm shift in medicine and healthcare

Chakraborty, C., Bhattacharya, M., Pal, S., & Lee, S. (2023) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2023.100164 · Cited by 295 · see citing works

MoFlow: An Invertible Flow Model for Generating Molecular Graphs

Zang, C., & Wang, F. (2020) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/3394486.3403104 · Cited by 272 · see citing works

GEOM, energy-annotated molecular conformations for property prediction and molecular generation

Axelrod, S., & Gómez‐Bombarelli, R. (2022) · Scientific Data · doi:10.1038/s41597-022-01288-4 · Cited by 269 · see citing works

Generative Adversarial Networks for Crystal Structure Prediction

Kim, S., Noh, J., Gu, G. H., Aspuru‐Guzik, A., & Jung, Y. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00426 · Cited by 266 · see citing works

InteractionGraphNet: A Novel and Efficient Deep Graph Representation Learning Framework for Accurate Protein–Ligand Interaction Predictions

Jiang, D., Hsieh, C., Wu, Z., Kang, Y., Wang, J., Wang, E., Liao, B., Shen, C., Xu, L., Wu, J. F., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01830 · Cited by 260 · see citing works

Assessing the impact of generative AI on medicinal chemistry

Walters, W. P., & Murcko, M. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0418-2 · Cited by 262 · see citing works

An artificial intelligence accelerated virtual screening platform for drug discovery

(2024) · doi:10.1038/s41467-024-52061-7 · Cited by 259 · see citing works

Big data in basic and translational cancer research

Jiang, P., Sinha, S., Aldape, K., Hannenhalli, S., Sahinalp, C., & Ruppin, E. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00502-0 · Cited by 254 · see citing works

Survey on Explainable AI: From Approaches, Limitations and Applications Aspects

Yang, W., Wei, Y.-C., Wei, H., Chen, Y., Huang, G., Li, X., Li, R., Yao, N., Wang, X., Gu, X., et al. (2023) · Human-Centric Intelligent Systems · doi:10.1007/s44230-023-00038-y · Cited by 275 · see citing works

Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development

Arshadi, A. K., Webb, J., Salem, M., Cruz, E., Calad-Thomson, S., Ghadirian, N., Collins, J., Diez‐Cecilia, E., Kelly, B., Goodarzi, H., et al. (2020) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2020.00065 · Cited by 245 · see citing works

Generative Models for De Novo Drug Design

Tong, X., Liu, X., Tan, X., Li, X., Jiang, J., Xiong, Z., Xu, T., Jiang, H., Qiao, N., & Zheng, M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00927 · Cited by 242 · see citing works

Artificial Intelligence for Drug Discovery: Are We There Yet?

Hasselgren, C., & Oprea, T. I. (2024) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-040323-040828 · Cited by 236 · see citing works

Advanced machine-learning techniques in drug discovery

Elbadawi, M., Gaisford, S., & Basit, A. W. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.003 · Cited by 229 · see citing works

Retrosynthetic accessibility score (RAscore) – rapid machine learned synthesizability classification from AI driven retrosynthetic planning

Thakkar, A., Chadimová, V., Bjerrum, E. J., Engkvist, O., & Reymond, J. (2021) · Chemical Science · doi:10.1039/d0sc05401a · Cited by 231 · see citing works

Artificial intelligence in drug discovery: applications and techniques

Deng, J., Yang, Z., Ojima, I., Samaras, D., & Wang, F. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab430 · Cited by 236 · see citing works

Transformer neural network for protein-specific de novo drug generation as a machine translation problem

Grechishnikova, D. (2021) · Scientific Reports · doi:10.1038/s41598-020-79682-4 · Cited by 224 · see citing works

Artificial intelligence and machine learning in drug discovery and development

Patel, V. J., & Shah, M. (2021) · Intelligent Medicine · doi:10.1016/j.imed.2021.10.001 · Cited by 234 · see citing works

Natural product drug discovery in the artificial intelligence era

Saldívar‐González, F. I., Aldas-Bulos, V. D., Medina‐Franco, J. L., & Plisson, F. (2021) · Chemical Science · doi:10.1039/d1sc04471k · Cited by 227 · see citing works

Learning Molecular Representations for Medicinal Chemistry

Chuang, K. V., Gunsalus, L. M., & Keiser, M. J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00385 · Cited by 227 · see citing works

A deep learning framework for high-throughput mechanism-driven phenotype compound screening and its application to COVID-19 drug repurposing

Pham, T.-H., Qiu, Y., Zeng, J., Xie, L., & Zhang, P. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-020-00285-9 · Cited by 219 · see citing works

Chemistry42: An AI-Driven Platform for Molecular Design and Optimization

Ivanenkov, Y. A., Polykovskiy, D., Bezrukov, D., Zagribelnyy, B., Aladinskiy, V., Kamya, P., Aliper, A., Ren, F., & Zhavoronkov, A. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01191 · Cited by 231 · see citing works

Machine learning in polymer informatics

Sha, W., Li, Y., Tang, S., Tian, J., Zhao, Y., Guo, Y., Zhang, W., Zhang, X., Lu, S., Cao, Y., et al. (2021) · InfoMat · doi:10.1002/inf2.12167 · Cited by 202 · see citing works

Artificial intelligence foundation for therapeutic science

Huang, K., Fu, T., Gao, W., Zhao, Y., Roohani, Y., Leskovec, J., Coley, C. W., Xiao, C., Sun, J., & Zitnik, M. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01131-2 · Cited by 207 · see citing works

Innovative Materials Science via Machine Learning

Gao, C., Min, X., Fang, M., Tao, T., Zheng, X., Liu, Y., Wu, X., & Huang, Z. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202108044 · Cited by 198 · see citing works

Unleashing the power of generative AI in drug discovery

Gangwal, A., & Lavecchia, A. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103992 · Cited by 195 · see citing works

Multi-constraint molecular generation based on conditional transformer, knowledge distillation and reinforcement learning

Wang, J., Hsieh, C., Wang, M., Wang, X., Wu, Z., Jiang, D., Liao, B., Zhang, X., Yang, B., He, Q., et al. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00403-1 · Cited by 193 · see citing works

Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities

Gangwal, A., Ansari, A., Ahmad, I., Azad, A. K., Kumarasamy, V., Subramaniyan, V., & Wong, L. S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1331062 · Cited by 204 · see citing works

Graph neural networks for automated de novo drug design

Xiong, J., Xiong, Z., Chen, K., Jiang, H., & Zheng, M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.011 · Cited by 192 · see citing works

Generative Deep Learning for Targeted Compound Design

de Sousa, T. F., Correia, J. V. M., Pereira, V., & Rocha, M. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01496 · Cited by 192 · see citing works

Prediction of drug efficacy from transcriptional profiles with deep learning

Zhu, J., Wang, J., Wang, X., Gao, M., Guo, B., Gao, M., Liu, J., Yu, Y., Wang, L., Kong, W., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00946-z · Cited by 193 · see citing works

Machine-Learning-Assisted De Novo Design of Organic Molecules and Polymers: Opportunities and Challenges

Chen, G., Shen, Z., Iyer, A., Ghumman, U. F., Tang, S., Bi, J., Chen, W., & Li, Y. (2020) · Polymers · doi:10.3390/polym12010163 · Cited by 193 · see citing works

A transformer-based model to predict peptide–HLA class I binding and optimize mutated peptides for vaccine design

Chu, Y., Zhang, Y., Wang, Q., Zhang, L., Wang, X., Wang, Y., Salahub, D. R., Xu, Q., Wang, J., Jiang, X. X., et al. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00459-7 · Cited by 190 · see citing works

Biohorology and biomarkers of aging: Current state-of-the-art, challenges and opportunities

Galkin, F., Mamoshina, P., Aliper, A., de Magalhães, J. P., Gladyshev, V. N., & Zhavoronkov, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101050 · Cited by 189 · see citing works

Generative chemistry: drug discovery with deep learning generative models

Bian, Y., & Xie, X.-Q. (2021) · Journal of Molecular Modeling · doi:10.1007/s00894-021-04674-8 · Cited by 193 · see citing works

Deep learning for drug repurposing: Methods, databases, and applications

Pan, X., Lin, X., Cao, D., Zeng, X., Yu, P. S., He, L., Nussinov, R., & Cheng, F. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1597 · Cited by 189 · see citing works

Combining generative artificial intelligence and on-chip synthesis for de novo drug design

Grisoni, F., Huisman, B. J. H., Button, A. L., Moret, M., Atz, K., Merk, D., & Schneider, G. (2021) · Science Advances · doi:10.1126/sciadv.abg3338 · Cited by 190 · see citing works

Evaluation guidelines for machine learning tools in the chemical sciences

Bender, A., Schneider, N., Segler, M., Walters, W. P., Engkvist, O., & Rodrigues, T. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00391-9 · Cited by 186 · see citing works

Game theory interpretation of digital soil mapping convolutional neural networks

Padarian, J., McBratney, A. B., & Minasny, B. (2020) · SOIL · doi:10.5194/soil-6-389-2020 · Cited by 182 · see citing works

Enhancing preclinical drug discovery with artificial intelligence

Vijayan, R., Kihlberg, J. O., Cross, J. B., & Poongavanam, V. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.023 · Cited by 184 · see citing works

Artificial intelligence and radical innovation: an opportunity for all companies?

Grashof, N., & Kopka, A. (2022) · Small Business Economics · doi:10.1007/s11187-022-00698-3 · Cited by 192 · see citing works

Deep Retrosynthetic Reaction Prediction using Local Reactivity and Global Attention

Chen, S., & Jung, Y. (2021) · JACS Au · doi:10.1021/jacsau.1c00246 · Cited by 178 · see citing works

AI on drugs: can artificial intelligence accelerate drug development? Evidence from a large-scale examination of bio-Pharma firms

Lou, B., & Wu, L. (2021) · MIS Quarterly · doi:10.25300/misq/2021/16565 · Cited by 177 · see citing works

Generative machine learning for de novo drug discovery: A systematic review

Martinelli, D. D. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105403 · Cited by 177 · see citing works

Artificial intelligence in cancer therapy

Ho, D. (2020) · Science · doi:10.1126/science.aaz3023 · Cited by 164 · see citing works

Quantum Machine Learning Algorithms for Drug Discovery Applications

Batra, K., Zorn, K. M., Foil, D. H., Minerali, E., Gawriljuk, V. O., Lane, T. R., & Ekins, S. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00166 · Cited by 176 · see citing works

Machine learning-aided generative molecular design

Du, Y., Jamasb, A. R., Guo, J., Fu, T., Harris, C., Wang, Y., Duan, C., Lió, P., Schwaller, P., & Blundell, T. L. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-024-00843-5 · Cited by 193 · see citing works

Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery

Hinkson, I. V., Madej, B. D., & Stahlberg, E. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00770 · Cited by 178 · see citing works

Artificial intelligence in chemistry and drug design

Brown, N., Ertl, P., Lewis, R., Luksch, T., Reker, D., & Schneider, N. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00317-x · Cited by 165 · see citing works

Machine Learning on DNA-Encoded Libraries: A New Paradigm for Hit Finding

McCloskey, K., Sigel, E. A., Kearnes, S. M., Xue, L., Tian, X., Moccia, D., Gikunju, D., Bazzaz, S., Chan, B., Clark, M., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00452 · Cited by 163 · see citing works

Delocalized, asynchronous, closed-loop discovery of organic laser emitters

Strieth‐Kalthoff, F., Hao, H., Rathore, V., Derasp, J. S., Gaudin, T., Angello, N. H., Seifrid, M. T., Trushina, E., Guy, M. A., Liu, J., et al. (2024) · Science · doi:10.1126/science.adk9227 · Cited by 161 · see citing works

Developmental trend of immunoassays for monitoring hazards in food samples: A review

Xiao, X., Hu, S., Lai, X., Peng, J., & Lai, W. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.02.045 · Cited by 161 · see citing works

Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?

Zhavoronkov, A., Vanhaelen, Q., & Oprea, T. I. (2020) · Clinical Pharmacology &amp; Therapeutics · doi:10.1002/cpt.1795 · Cited by 159 · see citing works

Leveraging Uncertainty in Machine Learning Accelerates Biological Discovery and Design

Hie, B., Bryson, B. D., & Berger, B. (2020) · Cell Systems · doi:10.1016/j.cels.2020.09.007 · Cited by 154 · see citing works

Out-of-the-box deep learning prediction of pharmaceutical properties by broadly learned knowledge-based molecular representations

Shen, W. X., Zeng, X. L., Zhu, F., Wang, Y. L., Chu, Q., Tan, Y. C., Jiang, Y. Y., & Chen, Y. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00301-6 · Cited by 156 · see citing works

Towards artificial intelligence-enabled extracellular vesicle precision drug delivery

Greenberg, Z., Graim, K. S., & He, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114974 · Cited by 160 · see citing works

Application advances of deep learning methods for de novo drug design and molecular dynamics simulation

Bai, Q., Liu, S., Tian, Y., Xu, T., Banegas‐Luna, A. J., Pérez‐Sánchez, H., Huang, J., Liu, H., & Yao, X. (2022) · WIREs Computational Molecular Science · doi:10.1002/wcms.1581 · Cited by 156 · see citing works

Deep learning identifies DDR1 kinase inhibitors

Crunkhorn, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/d41573-019-00170-0 · Cited by 3 · see citing works

Design and Synthesis of DDR1 Inhibitors with a Desired Pharmacophore Using Deep Generative Models

Yoshimori, A., Asawa, Y., Kawasaki, E., Tasaka, T., Matsuda, S., Sekikawa, T., Tanabe, S., Neya, M., Natsugari, H., & Kanai, C. (2020) · ChemMedChem · doi:10.1002/cmdc.202000786 · Cited by 45 · see citing works

Discovery of Pyrazolo[3,4- d ]pyridazinone Derivatives as Selective DDR1 Inhibitors via Deep Learning Based Design, Synthesis, and Biological Evaluation

Tan, X., Li, C., Yang, R., Zhao, S., Li, F., Li, X., Chen, L., Wan, X., Liu, X., Yang, T., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01205 · Cited by 68 · see citing works

Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor

Li, Y., Zhang, L., Wang, Y., Zou, J., Yang, R., Luo, X., Wu, C., Yang, W. M., Tian, C., Xu, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34692-w · Cited by 106 · see citing works

Machine Learning-Driven De Novo Design of DDP-4 Targeted Drug Molecules Using RNN-Based Generative Models and Reinforcement Learning

Lou, J. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2025.au28436